TY - JOUR
T1 - Hodgkin lymphoma
T2 - Highlights from the 2012 European School of Hematology International Conference
AU - Carella, Angelo Michele
PY - 2013/2
Y1 - 2013/2
N2 - ESH International Conference on Lymphomas Marseille, France, 28-30 October 2012 The ESH International Conference on Lymphomas gathered clinicians and scientists involved in all aspects of clinical treatment and biology of lymphomas. The 2012 International Conference was held in Marseille, France, and presented an appealing program. Of particular interest was the session dedicated to Hodgkin lymphoma. Our knowledge on the pathology of Hodgkin lymphoma and on the new therapeutic possibilities has changed greatly during the last three decades. During the session, the speakers focused on the results of conventional chemotherapy and on the new drugs for resistant/relapsed patients.
AB - ESH International Conference on Lymphomas Marseille, France, 28-30 October 2012 The ESH International Conference on Lymphomas gathered clinicians and scientists involved in all aspects of clinical treatment and biology of lymphomas. The 2012 International Conference was held in Marseille, France, and presented an appealing program. Of particular interest was the session dedicated to Hodgkin lymphoma. Our knowledge on the pathology of Hodgkin lymphoma and on the new therapeutic possibilities has changed greatly during the last three decades. During the session, the speakers focused on the results of conventional chemotherapy and on the new drugs for resistant/relapsed patients.
UR - http://www.scopus.com/inward/record.url?scp=84873366196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873366196&partnerID=8YFLogxK
U2 - 10.1586/ehm.12.73
DO - 10.1586/ehm.12.73
M3 - Article
C2 - 23373777
AN - SCOPUS:84873366196
VL - 6
SP - 35
EP - 37
JO - Expert Review of Hematology
JF - Expert Review of Hematology
SN - 1747-4086
IS - 1
ER -